Predictors of Long-Term Survival among High-Grade Serous Ovarian Cancer Patients

被引:19
作者
Clarke, Christina L. [1 ]
Kushi, Lawrence H. [2 ]
Chubak, Jessica [3 ]
Pawloski, Pamala A. [4 ]
Bulkley, Joanna E. [5 ]
Epstein, Mara M. [6 ,7 ]
Burnett-Hartman, Andrea N. [1 ]
Powell, Bethan [8 ]
Pearce, Celeste L. [9 ]
Feigelson, Heather Spencer [1 ]
机构
[1] Kaiser Permanente Colorado, Inst Hlth Res, Denver, CO USA
[2] Kaiser Permanente Northern Calif, Div Res, Oakland, CA USA
[3] Kaiser Permanente Washington, Hlth Res Inst, Seattle, WA USA
[4] HealthPartners Inst, Bloomington, MN USA
[5] Kaiser Permanente Northwest, Ctr Hlth Res, Portland, OR USA
[6] Meyers Primary Care Inst, Worcester, MA USA
[7] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA
[8] Kaiser Permanente Northern Calif, Gynecol Oncol Program, San Francisco, CA USA
[9] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA
关键词
D O I
10.1158/1055-9965.EPI-18-1324
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Relatively little is known about factors associated with long-term survival (LTS) following a diagnosis of ovarian cancer. Methods: We conducted a retrospective study of high-grade serous ovarian cancer (HGSOC) to explore predictors of LTS (defined as >= 7 years of survival) using electronic medical record data from a network of integrated health care systems. Multivariable logistic regression with forward selection was used to compare characteristics of women who survived >= 7 years after diagnosis (n = 148) to those who died within 7 years of diagnosis (n = 494). Results: Our final model included study site, age, stage at diagnosis, CA-125, comorbidity score, receipt of chemotherapy, BMI, and four separate comorbid conditions: weight loss, depression, hypothyroidism, and liver disease. Of these, only younger age, lower stage, and depression were statistically significantly associated with LTS. Conclusions: We did not identify any new characteristics associated with HGSOC survival. Impact: Prognosis of ovarian cancer generally remains poor. Large, pooled studies of ovarian cancer are needed to identify characteristics that may improve survival.
引用
收藏
页码:996 / 999
页数:4
相关论文
共 50 条
  • [41] Disparities in treatment modalities and survival among elderly high grade serous ovarian cancer patients
    Shu, Tong
    Cai, Yan
    Zheng, Hong
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A172 - A172
  • [42] Germline polymorphisms in cancer stem cell genes associate with survival among women with high-grade serous ovarian cancer
    Reid, Brett M.
    Permuth, Jennifer B.
    Chen, Zhihua
    Chen, Ann
    Sellers, Thomas A.
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [43] Multiple lines of chemotherapy for patients with high-grade ovarian cancer: Predictors for response and effect on survival
    Kessous, Roy
    Wissing, Michel D.
    Laskov, Ido
    Abitbol, Jeremie
    Bitharas, Joanna
    Agnihotram, Venkata R.
    Yasmeen, Amber
    Salvador, Shannon
    Lau, Susie
    Gotlieb, Walter H.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2021, 148 (09) : 2304 - 2312
  • [44] T-cell activation is associated with high-grade serous ovarian cancer survival
    Wang, Lei
    Sun, Wenjie
    Zhang, Guoan
    Huo, Jingrui
    Tian, Yi
    Zhang, Yan
    Yang, Xiaohui
    Liu, Yingfu
    [J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2022, 48 (08) : 2189 - 2197
  • [45] Nuclear SYK phosphorylation is associated with poor survival in high-grade serous ovarian cancer
    Yu, Y.
    Suryo, Y.
    Davidson, B.
    Africano, A. A.
    Fader, A. N.
    Wang, T. L.
    Shih, I. M.
    [J]. GYNECOLOGIC ONCOLOGY, 2017, 145 : 129 - 129
  • [46] IMPACT ON SURVIVAL OF INTEGRATIVE SYSTEMIC AND LOCAL METABOLOMICS IN HIGH-GRADE SEROUS OVARIAN CANCER
    Aust, S.
    Bachmayr-Heyda, A.
    Auer, K.
    Meier, S.
    Schmetterer, K.
    Dekan, S.
    Gerner, C.
    Pils, D.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 335 - 335
  • [47] Association of fusion genes with clinical outcomes and survival in high-grade serous ovarian cancer
    Newtson, A. M.
    Reyes, H. D.
    Lyons, Y. A.
    Cardillo, N. D.
    Russo, D.
    Devor, E.
    Goodheart, M. J.
    Gonzalez-Bosquet, J.
    [J]. GYNECOLOGIC ONCOLOGY, 2020, 159 : 103 - 104
  • [48] Integrative Systemic and Local Metabolomics with Impact on Survival in High-Grade Serous Ovarian Cancer
    Bachmayr-Heyda, Anna
    Aust, Stefanie
    Auer, Katharina
    Meier, Samuel M.
    Schmetterer, Klaus G.
    Dekan, Sabine
    Gerner, Christopher
    Pils, Dietmar
    [J]. CLINICAL CANCER RESEARCH, 2017, 23 (08) : 2081 - 2092
  • [49] IMPACT ON SURVIVAL OF INTEGRATIVE SYSTEMIC AND LOCAL METABOLOMICS IN HIGH-GRADE SEROUS OVARIAN CANCER
    Aust, S.
    Bachmayr-Heyda, A.
    Auer, K.
    Meier, S.
    Schmetterer, K.
    Dekan, S.
    Gerner, C.
    Pils, D.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1798 - 1798
  • [50] Wnt Signaling and Survival of Women With High-Grade Serous Ovarian Cancer A Brief Report
    Seagle, Brandon-Luke L.
    Dandapani, Monica
    Yeh, Judy Y.
    Shahabi, Shohreh
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 (06) : 1078 - 1080